Company
Senior Executive Officers
Board of Directors
Ethics Advisory Board
Careers
Glossary
Contact Us
Technology
Regenerative Medicine
Blastomere Program
Cellular Reprogramming
Stem Cell Differentiation
Intellectual Property
Pipeline
Overview
Potential Markets
Myoblast Program
RPE Program
Hemangioblast (HG) Cell Program
News and Media
ACT Corporate Overview
Press Releases
Conference Presentations
Media Gallery
Media Contact
Safe Medication from Canadian Pharmacies
Investors
Investors Overview
Research Reports
Corporate Governance
Committee Charters
Whistleblower Hotline
Sitemap
Page 4 of 5 :
Previous
:
Next
Pages
Ethics Advisory Board
Event Calendar
Executive Researchers
Executives
Fact Sheet
First Clinical Trial Using Embryonic Stem Cells to Treat Dry AMD
First Human Embryonic Stem Cell Line Without Destroying an Embryo
Frequently Asked Questions
Gary Rabin
Generation of functional hemangioblasts from human embryonic stem cells
Glossary
GMP-compliant Human RPE Cells Derived from Embryonic Stem Cell Lines Rescue Visual Function In a Rat Model for Photoreceptor Degeneration
Hemangioblast (HG) Cell Program
How to Find Safe Medication Options from Canadian Pharmacies
Human Cloning Has Led to the Creation of New Stem Cells
Human Embryonic Stem Cell (hESC)- derived Retinal Pigment Epithelial (RPE) Cells (hESC-derived RPE Cells)
Human Embryonic Stem Cell Line
Human Embryonic Stem Cell Lines Generated without Embryo Destruction
Human Embryonic Stem Cell Lines Generated without Embryo Destruction
Human Embryonic Stem Cell–Derived Cells Rescue Visual Function in Dystrophic RCS Rats
Human Embryonic Stem Cells in the Medicine
Human Somatic Cell Nuclear Transfer
Images of the Somatic Cell Nuclear Transfer Process
Intellectual Property
Investors Overview
Legal
Long-Term Bovine Hematopoietic Engraftment with Clone-Derived Stem Cells
Manufacturing Platform – Pluripotent Stem Cell Sources
Media Contact
Media Gallery
Mission Statement
Multiple Pluripotent Cell Platforms
Myoblast Program
News
Nih Approves Advanced Cell Technology’s Stem Cell Line for Federal Funding
Ongoing Clinical Trials
PGD: Generation of Human Embryonic Stem Cells That Maintains Developmental Potential Of Embryo
Pipeline Overview
Potential Markets
PR SCIENTIFIC BACKGROUND on Gaur & Bucardo
Press Releases: ACT and Roslin Cells Announce Collaboration for Storage and Distribution of Embryonic Stem Cells Using ACT's Blastomere Technology
Quarterly Reports
Research Reports
Researchers Develop Primate Stem Cells Without Creating Viable Embryos
Resent Press Releases
Retinal Pigment Epithelial Cell Program
Retinal Pigment Epithelial Cell Program
Retinal Pigment Epithelium
Retinal Pigment Treated with Stem Cells
Retinal Pigmented Epithelial Cell Program
